These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2117284

  • 1. New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data.
    Debruyne FM, Franssen MP, Beniers AJ, Schalken JA, de Mulder PH.
    Prog Clin Biol Res; 1990; 350():243-55. PubMed ID: 2117284
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant alpha-2 or gamma interferon in the treatment of metastatic renal cell carcinoma: results of two phase II/III trials.
    Otto U, Schneider AW, Conrad S, Klosterhalfen H.
    Prog Clin Biol Res; 1990; 350():275-82. PubMed ID: 2117287
    [No Abstract] [Full Text] [Related]

  • 3. Anti-tumor effects of interleukin 2 against renal cell carcinoma. In vitro study and clinical application.
    Marumo K, Tazaki H.
    Prog Clin Biol Res; 1990; 350():263-73. PubMed ID: 2117286
    [No Abstract] [Full Text] [Related]

  • 4. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 5. Cyclic interferon gamma application in patients with renal cell carcinoma.
    Grups JW, Frohmüller HG.
    Prog Clin Biol Res; 1990 Oct; 350():257-62. PubMed ID: 2117285
    [No Abstract] [Full Text] [Related]

  • 6. The antitumor effects of IFN- beta against human renal cell carcinoma in athymic nude mice.
    Shirahama T, Kayajima T, Ohi Y.
    In Vivo; 1989 Oct; 3(5):345-9. PubMed ID: 2519876
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon-alpha and interleukin-2 in the treatment of renal cell cancer.
    Holdener EE, Emmons RP, Brunda M, Evans L, Levitt D.
    Prog Clin Biol Res; 1990 Oct; 348():61-9. PubMed ID: 2201034
    [No Abstract] [Full Text] [Related]

  • 9. Interferons in renal-cell carcinoma: status and prospects.
    De Mulder PH, Debruyne FM, Beniers AJ.
    Prog Clin Biol Res; 1990 Oct; 348():49-59. PubMed ID: 1696737
    [No Abstract] [Full Text] [Related]

  • 10. Antitumor effects of alpha-interferon and gamma-interferon on a murine renal cancer (Renca) in vitro and in vivo.
    Sayers TJ, Wiltrout TA, McCormick K, Husted C, Wiltrout RH.
    Cancer Res; 1990 Sep 01; 50(17):5414-20. PubMed ID: 2117482
    [Abstract] [Full Text] [Related]

  • 11. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
    Onishi T, Machida T, Masuda F, Iizuka N, Nakauchi K, Furuta N, Shirakawa H.
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug 20; 25(8):1571-8. PubMed ID: 2121869
    [Abstract] [Full Text] [Related]

  • 12. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
    Baisch H, Otto U, Klöppel G.
    Cancer Res; 1990 Oct 01; 50(19):6389-95. PubMed ID: 2400997
    [Abstract] [Full Text] [Related]

  • 13. Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial.
    Otto U, Conrad S, Schneider AW, Klosterhalfen H.
    Arzneimittelforschung; 1988 Nov 01; 38(11):1658-60. PubMed ID: 3145743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II study of recombinant interferon alpha-C in patients with metastatic renal cell carcinoma.
    Merimsky O, Inbar M, Merimsky E, Kovner F, Spitzer E, Laufer R, Braf Z, Chaitchik S.
    Mol Biother; 1990 Sep 01; 2(3):155-9. PubMed ID: 2222899
    [Abstract] [Full Text] [Related]

  • 16. Acute right ventricular heart failure in a patient with renal cell carcinoma after interferon therapy.
    Kramers C, de Mulder PH, Barth JD, Wagener DJ.
    Neth J Med; 1993 Feb 01; 42(1-2):65-8. PubMed ID: 8446228
    [Abstract] [Full Text] [Related]

  • 17. [Antiproliferative effect of interferon-alpha on human renal cell carcinoma in clonogenic assay--single and combination effect with cancer chemotherapeutic agent].
    Ohmura K, Tsukamoto T.
    Hinyokika Kiyo; 1989 May 01; 35(5):737-47. PubMed ID: 2801371
    [Abstract] [Full Text] [Related]

  • 18. Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.
    Figlin RA, Pierce WC, Belldegrun A.
    Semin Oncol; 1993 Dec 01; 20(6 Suppl 9):11-5. PubMed ID: 8284686
    [No Abstract] [Full Text] [Related]

  • 19. Effects of MAb BW 494/32 and rTNF-a/rIFN-g alone and in combination in nude mice bearing xenografts of human gastrointestinal/pancreatic carcinomas.
    Klapdor R, Schwarzenberg O, Kühl JS, Franke N, Bahlo M.
    Strahlenther Onkol; 1989 Jul 01; 165(7):549-50. PubMed ID: 2501886
    [No Abstract] [Full Text] [Related]

  • 20. Alpha interferon therapy for renal cell carcinoma: summary of four collaborative trials. Cancer Research Committee.
    Aso Y, Umeda T, Niijima T.
    Prog Clin Biol Res; 1989 Jul 01; 303():653-9. PubMed ID: 2675017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.